As immunosuppressive cells within tumor tissues use CCR7 to migrate to distal immune organs and promote tumor progression, Niu et al. engineered a family of CAR-Ms targeting CCR7 to disrupt this signal transmission. Here, CCR7 is linked to neoplasm.